Clinica
St Jude's neuromodulator fails in migraine trial – US approval unlikely?
23 June 2011
Elizabeth Cairns
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
- INS 2011: Medtronic CE marks new neurostim technique to relieve pain; St Jude widens market for Epiducer
- Medtronic's ablation system beats drug therapy in persistent AF trial, but fails on safety
- Boston's Watchman edges closer to US approval with feasibility study success
Other Informa News
EVENTS
